Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women’s breast cancer tumors
暂无分享,去创建一个
[1] R. Smith,et al. Breast cancer epidemiology. , 2018 .
[2] Soheil Saadat,et al. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. , 2015, Cancer epidemiology.
[3] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[4] P. Vineis,et al. Global cancer patterns: causes and prevention , 2014, The Lancet.
[5] S. Roberts,et al. Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord , 2013, BioMed research international.
[6] A. Weaver,et al. Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation , 2013, International journal of dentistry.
[7] Shahpar Haghighat,et al. Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National Study , 2012, Iranian Red Crescent medical journal.
[8] F. Salvatore,et al. Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[9] Mohamad Amin Pourhoseingholi,et al. Increased trend of breast cancer mortality in Iran. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[10] M. Espié,et al. Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches , 2011, British Journal of Cancer.
[11] F. Lupu,et al. Differential regulation of human and murine P-selectin expression and function in vivo , 2010, The Journal of experimental medicine.
[12] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[13] S. Schnitt,et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines , 2010, Breast Cancer Research.
[14] S. Coughlin,et al. Breast cancer as a global health concern. , 2009, Cancer epidemiology.
[15] O. Tetsu,et al. Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2 , 2009, PloS one.
[16] Paolo Romano,et al. Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines , 2008, Nucleic Acids Res..
[17] Dirk Hasenclever,et al. Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer , 2008, Clinical Cancer Research.
[18] M. Ringnér,et al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors , 2008, Breast Cancer Research.
[19] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[20] O. Gires,et al. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. , 2008, Frontiers in bioscience : a journal and virtual library.
[21] Carlos Caldas,et al. Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line , 2008, International journal of cancer.
[22] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[23] I. Nagtegaal,et al. Loss of membranous Ep-CAM in budding colorectal carcinoma cells , 2007, Modern Pathology.
[24] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[25] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[26] H. Moch,et al. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. , 2006, Gynecologic oncology.
[27] N. Kapucuoglu,et al. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. , 2006, Pathology, research and practice.
[28] M Vasei,et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers , 2006, British Journal of Cancer.
[29] A. Ashworth,et al. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells , 2005, Breast Cancer Research.
[30] S. Lim. CD24 and human carcinoma: tumor biological aspects. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[31] P. Tan,et al. Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death , 2005, Modern Pathology.
[32] David Botstein,et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.
[33] A. Bielawska,et al. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts , 2004, The Prostate.
[34] I. Nagtegaal,et al. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. , 2003, The American journal of pathology.
[35] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] Y. Le Marchand-Brustel,et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.
[37] B. Wollenberg,et al. Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. , 2003, Cancer letters.
[38] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Kristiansen,et al. Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule , 2003, Journal of Molecular Histology.
[40] J. R. Reeves,et al. Evaluating HER2 amplification and overexpression in breast cancer , 2001, The Journal of pathology.
[41] B. Rosner,et al. Measurement error correction in nutritional epidemiology based on individual foods, with application to the relation of diet to breast cancer. , 2001, American journal of epidemiology.
[42] J W Gamel,et al. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients , 2001, Statistical methods in medical research.
[43] J. Hopper,et al. Genetic epidemiology of female breast cancer. , 2001, Seminars in cancer biology.
[44] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Johanson. Critical review of the epidemiology of gastroesophageal reflux disease with specific comparisons to asthma and breast cancer. , 2001, The American journal of gastroenterology.
[46] E. Strehler,et al. The Tumor-sensitive Calmodulin-like Protein Is a Specific Light Chain of Human Unconventional Myosin X* , 2001, The Journal of Biological Chemistry.
[47] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[48] C. Watson,et al. A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland , 2000, Breast Cancer Research.
[49] M. Foley,et al. Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development. , 1999, Neoplasia.
[50] A. Green,et al. Short-term primary culture of epithelial cells derived from human breast tumours. , 1998, British Journal of Cancer.
[51] P. Altevogt,et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.
[52] R. Cote,et al. Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[53] A. Green,et al. A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples , 1996, International journal of cancer.
[54] H. Schulman,et al. Selective activation and inhibition of calmodulin-dependent enzymes by a calmodulin-like protein found in human epithelial cells. , 1994, European journal of biochemistry.
[55] R. Tarone,et al. Involution and the etiology of breast cancer , 1994, Cancer.
[56] J. Cox,et al. Cation binding and conformation of human calmodulin-like protein. , 1993, Biochemistry.
[57] K. Namboodiri,et al. Breast cancer risk: effects of estrogen replacement therapy and body mass. , 1993, Journal of the National Cancer Institute.
[58] I. Henderson. Risk factors for breast cancer development , 1993, Cancer.
[59] J. Cox,et al. Characterization of the human calmodulin-like protein expressed in Escherichia coli. , 1992, Biochemistry.
[60] Sam W. Lee,et al. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[61] P. Yaswen,et al. Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[62] E. Lane,et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. , 1989, Journal of cell science.
[63] V. Band,et al. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[64] S. L. Hammond,et al. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Herlyn,et al. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. S. Steinberg,et al. Contact inhibitions of overlapping and differential cell adhesion: a sufficient model for the control of certain cell culture morphologies. , 1974, Journal of cell science.
[67] L. Sachs,et al. In Vitro Cell Transformation with Chemical Carcinogens , 1963, Nature.
[68] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[69] T. Sebo,et al. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. , 2009, Journal of prosthodontics : official journal of the American College of Prosthodontists.
[70] H. Hameister,et al. Localization of the intronless gene coding for calmodulin-like protein CLP to human chromosome 10p13-ter , 2004, Human Genetics.
[71] S. Ethier,et al. Isolation and Culture of Human Breast Cancer Cells from Primary Tumors and Metastases , 2000 .
[72] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[73] P. Kincade,et al. CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.
[74] J. Peterson. Animal Cell Culture: A Practical Approach , 1993, The Yale Journal of Biology and Medicine.
[75] K. Ebeling,et al. [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.